60 years ago we began using lithium in psychiatry. Countless studies support its efficacy as a mood stabiliser, some even suggest neuroprotective, telomere-preserving & anti-suicidal effects.
BUT #lithium remains under-prescribed. Why?
https://t.co/3QW4Wwc387
"Brain stimulation treatment has changed my life in so many ways," – Shelley, CAMH Patient. A new $10M donation from the Temerty family means brain stimulation will continue to transform lives for patients like Shelley. Read more: https://t.co/6F9OScKJeV
Four distinct response patterns to TMS brain stimulation therapy for refractory major depression point to possibility of individualized treatments. https://t.co/YMC7qzBWzR
#addiction#anxiety#depression#TMS
Homeless Ontarians discharged from a psychiatric hospital are twice as likely as non-homeless to return to the ED for psychiatric care within a month: recent @ICESOntario@CAMHnews study by @KurdyakP links #housing and #mentalhealth https://t.co/rjlaM7VzoM #housingfirst
.@BigWhiteWallCA is an online forum for mental health discussions and resources that's available 24/7. @harriet_ek's presentation at the Future of Psychotherapy Conference demonstrates the real impact it's having for those struggling with mental health.
Computer-assisted cognitive-behavior therapy (CCBT) allows clinicians to deliver care to more patients than would be possible with standard CBT. This meta-analysis sought to determine if additional clinician support can increase the efficacy of CCBT. https://t.co/3MeDVkKsYA
Like many I’ve hoped that the observational epidemiological associations suggesting alcohol protected against cardiovascular disease (CVD) were true. Unfortunately, this is not the case, a paper by Iona Millwood, Zhengming Chen, Richard Peto et al shows https://t.co/yKeXqrGqhc
Risk of #psychosis with stimulants - small but real. Difference amphetamine vs methylphenidate relevant at population-level but not individual https://t.co/Tm8i39yIB9
Thought-provoking Reuter’s investigation piece on CFS/ME researchers highlights the need for scientists to engage in social media and promote their work https://t.co/jn0oSOlnJq
"The performance of suicide prediction models suggests that they offer limited practical utility in predicting suicide mortality." New @JAMAPsych paper out
https://t.co/WWb1KKIuCm
New study @CAMHnews shows that people with clinical depression have higher levels of a specific brain protein. These findings open the door for potential new treatments. https://t.co/FJ7spFFPcc
Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis https://t.co/U7VyxfW7PA
Do kids who take second-generation antipsychotics have the same risk of developing type 2 diabetes as adults taking these drugs? https://t.co/pj2PQMoq2I
Today FDA approves esketamine intranasal for resistant depression. First antidepressant since 1980s (!) with nove mechanism of action https://t.co/pWccGuoDCq
Clinical trial statistical thought of the day: clinical researchers who truly believe in treatment effect heterogeneity should show their commitment by multiplying sample sizes by 16 (the bare minimum for testing a SINGLE interaction effect).